DCZ0415, a potent TRIP13 inhibitor, impairs nonhomologous end joining repair and inhibits NF-kappaB activity. DCZ0415 induces anti-myeloma activity in vitro, in vivo, and in primary cells derived from drug-resistant myeloma patients[1].
Molecular Weight:
356.42
Purity:
99.81
CAS Number:
[2242470-43-3]
Formula:
C23H20N2O2
Target:
Apoptosis,NF-kappaB
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
